UK markets close in 7 hours 37 minutes

Caribou Biosciences, Inc. (CRBU)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.1300-0.2600 (-7.67%)
At close: 04:00PM EDT
3.1300 0.00 (0.00%)
After hours: 07:39PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-115,260
-102,070
-99,421
-66,923
-34,308
Depreciation & amortisation
3,646
3,525
1,622
984
900
Stock-based compensation
14,607
13,750
11,716
3,449
1,002
Change in working capital
-5,805
-7,318
-4,204
29,067
177
Accounts receivable
615
54
951
-1,003
-146
Accounts payable
3,037
1,819
-2,721
1,139
43
Other working capital
-115,085
-104,904
-98,020
-35,640
-34,530
Other non-cash items
4,736
3,275
-15
2,426
-1,789
Net cash provided by operating activities
-102,555
-93,291
-90,966
-32,519
-33,215
Cash flows from investing activities
Investments in property, plant and equipment
-12,530
-11,613
-7,054
-3,121
-1,315
Purchases of investments
-390,011
-394,758
-339,063
-173,276
0
Sales/maturities of investments
336,611
338,188
252,868
0
7,668
Net cash used for investing activities
-65,930
-68,183
-93,249
-176,397
6,363
Cash flows from financing activities
Debt repayment
-
-
0
-119
-113
Common stock issued
162,926
152,720
0
321,020
0
Net cash used provided by (used for) financing activities
165,141
154,298
2,133
433,429
1,735
Net change in cash
-3,344
-7,176
-182,082
224,513
-25,117
Cash at beginning of period
52,790
58,384
240,466
15,953
41,070
Cash at end of period
49,446
51,208
58,384
240,466
15,953
Free cash flow
Operating cash flow
-102,555
-93,291
-90,966
-32,519
-33,215
Capital expenditure
-12,530
-11,613
-7,054
-3,121
-1,315
Free cash flow
-115,085
-104,904
-98,020
-35,640
-34,530